DOPAMINE D1 RECEPTOR AGONIST PRO-DRUG COMPOUNDS AND DERIVATIVES

Details for Australian Patent Application No. 2002352474 (hide)

Owner SHIRE PHARMACEUTICAL DEVELOPMENT LTD

Inventors TILBROOK, Gary, Stuart

Pub. Number AU-A-2002352474

PCT Number PCT/GB02/05809

PCT Pub. Number WO2003/053936

Priority 0130576.2 20.12.01 GB

Filing date 19 December 2002

Wipo publication date 9 July 2003

International Classifications

C07D 223/16 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 025/16 Drugs for disorders of the nervous system

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0130576.2 20.12.01 GB

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2002352474

9 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352475-Program robots with off-line design

2002352473-A METHOD OF AND APPARATUS FOR HANDLING MESSAGES IN A MOBILE COMMUNICATIONS ENVIRONMENT